Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

Liver disease is the spectrum of liver damage ranging from simple steatosis called as
nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). Clinically …

Aims Multiple sclerosis (MS) still maintains increasing prevalence and poor prognosis, while
glucagon‐like peptide‐1 receptor (GLP‐1R) agonists show excellent neuroprotective …

Depression has emerged as a major cause of mortality globally. Many studies have reported
risk factors and mechanisms associated with depression, but it is as yet unclear how these …

Although obesity is a result of processes operating at multiple levels, most forms result from
decision-making behavior. The aim of this review was to examine the candidacy of temporal …

Obesity is a complex metabolic condition that can have a negative impact on one's health
and even result in mortality. The management of obesity has been addressed in a number of …

Obesity is defined as a chronic, complex, relapsing disease characterized by excessive
adipose tissue. Obesity impacts an individual's health by increasing complications such as …

Obesity incidence has pandemic proportions and is expected to increase even further.
Glucagon-like peptide-1 (GLP-1) based therapies are well-established pharmacological …

In recent years, the mammalian target of rapamycin (mTOR) has emerged as a master
integrator of upstream inputs, such as amino acids, growth factors and insulin availability …

Obesity is a major public health concern linked to health risks such as hypertension,
hyperlipidemia, type 2 diabetes mellitus (T2DM), stroke, metabolic syndrome, asthma, and …